Dr. Ewen Mullins:

I will pass to Mr. Spink in a moment but the Senator asked about our capacity to do this. We enabled our capacity when CRISPR first came to the fore and have maintained it since. We use it as a functional tool to study how genes behave in plants and whether knocking out certain genes impacts on certain traits in plants. It is very important as a research tool. This research has left us with capacity to capitalise quite quickly if the policy environment were to change. That is important because, as Professor O'Mara said, breeders across Europe are going to be doing that as well.